The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 50.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 4.00 (8.00%)
Open: 52.00
High: 52.00
Low: 52.00
Prev. Close: 52.00
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

20 Feb 2024 07:00

RNS Number : 6669D
Frenkel Topping Group PLC
20 February 2024
 

20 February 2024

 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Frenkel Topping Group plc

("Frenkel Topping", the "Company" or the "Group") 

Directorate Change

 

 

Frenkel Topping Group (AIM: FEN), a specialist independent financial advisor and wealth manager focused on asset protection for clients, is pleased to announce the appointment of Christopher Mills as Non-Executive Chairman with immediate effect.

 

Mr. Mills joined the board of Frenkel Topping as Non-Executive Director on 20 May 2020. Pursuant to a number of recent exits by Harwood Capital Management, Mr. Mills has consequently stepped down from a number of company boards as a non-executive director. This has given Mr. Mills capacity to take on the role as Non-Executive Chairman of Frenkel Topping and provided him more time to devote to the business in which he is a major shareholder.

 

Mr. Mills founded Harwood Capital Management in 2011, a successor to its former parent company JO Hambro Capital Management, which he co-founded in 1993 and of which he was formerly the Chief Investment Officer. He is currently the Chief Executive Officer and Investment Manager of North Atlantic Smaller Companies Investment Trust plc, a UK listed investment trust, and a non-executive Director of several companies including AssetCo plc, MJ Gleeson plc and Oryx International Growth Fund Limited.

 

Former Chairman, Tim Linacre, will remain on the Board of the Company, taking up the position of Senior Independent Non-Executive Director to support Frenkel Topping's strategy going forward. Mr. Linacre joined the board of Frenkel Topping in 2018 with more than 30 years' experience in financial services as a stockbroker and an investment banker and more latterly in financial public relations.

 

Chief Executive Officer, Richard Fraser, said: "Christopher has a deep understanding of the business and our ambitions and brings a wealth of experience in financial services and public companies to support us in our next stage of growth. I believe his guidance in the role of Chairman will be of great value to Frenkel Topping.

 

"I would also like to thank Tim for his contribution and dedication as Chairman since 2020 and I am delighted he has agreed to remain on the board and I look forward to working with him as Senior Independent Non-Executive Director in the future as we continue to grow the company.

 

 

As at the date of this announcement 38,350,000 ordinary shares of 0.5p each in the capital of the Company, representing 29.96 per cent. of the issued share capital of the Company are held by North Atlantic Smaller Companies Investment Trust plc ("NASCIT") a company of which Mr. Mills is both a shareholder and director.

 

 

For further information:     

Frenkel Topping Group plc

www.frenkeltoppinggroup.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

Cavendish Capital Markets Ltd (Nominated Advisor & Broker)

Tel: 020 7220 0500

Carl Holmes/Abigail Kelly/Fergus Sullivan (Corporate Finance)

Tim Redfern (ECM)

 

About Frenkel Topping Group

 

The Frenkel Topping Group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury (PI) and clinical negligence (CN).

 

For more than 30 years the Group has worked with legal professionals and injured clients themselves to provide pre-settlement, at-settlement and post-settlement services to help achieve the best long-term outcomes for clients after injury. It boasts a client retention rate of 99%.

 

Frenkel Topping Group is focused on consolidating the fragmented PI and CN space in order to provide the most comprehensive suite of services to clients and deliver a best-in-class service offering from immediately after injury or illness and for the rest of their lives.

 

The group's services include the Major Trauma Signposting Partnership service inside NHS Major Trauma Centres, expert witness, costs, tax and forensic accountancy, independent financial advice, investment management, and care and case management.

 

The Group's discretionary fund manager, Ascencia, manages financial portfolios for clients in unique circumstances, often who have received a financial settlement after litigation. In recent years Ascencia has diversified its portfolios to include a Sharia-law-compliant portfolio and a number of ESG portfolios in response to increased interest in socially responsible investing (SRI).

 

Frenkel Topping has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.

 

For more information visit: www.frenkeltoppinggroup.co.uk

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGMZVLKGDZM
Date   Source Headline
12th Jan 20127:00 amRNSTrading Statement
30th Nov 20114:12 pmRNSDirector/PDMR Shareholding
23rd Nov 201111:34 amRNSDirector/PDMR Shareholding
22nd Nov 20113:01 pmRNSEmployee Benefit Trust share purchase
27th Oct 20116:11 pmRNSDirector Shareholding and Holding in Company
20th Sep 20113:41 pmRNSDirector/PDMR Shareholding
6th Sep 201112:41 pmRNSExercise of options
21st Jul 20117:00 amRNSHalf Yearly Report
1st Jul 20117:00 amRNSChange of Adviser
20th Jun 20112:20 pmRNSDirector/PDMR Shareholding
15th Jun 20115:12 pmRNSCapital Reorganisation
13th Jun 20114:00 pmRNSHolding(s) in Company
10th Jun 201112:57 pmRNSCapital Reorganisation Update
8th Jun 20118:18 amRNSHolding(s) in Company
10th May 201110:31 amRNSResult of AGM
10th May 20117:00 amRNSAGM Statement
4th Apr 201112:09 pmRNSHolding(s) in Company
29th Mar 201112:33 pmRNSNotice of AGM
28th Mar 20111:58 pmRNSDirector/PDMR Shareholding
28th Mar 201110:34 amRNSDirector/PDMR Shareholding
24th Mar 20111:52 pmRNSIssue of Options
24th Mar 20117:00 amRNSFinal Results
2nd Feb 20114:21 pmRNSHolding(s) in Company
1st Feb 20119:48 amRNSHolding(s) in Company
15th Dec 20104:07 pmRNSDirectorate Change
30th Sep 20109:42 amRNSTotal Voting Rights
28th Sep 20104:27 pmRNSDirector/PDMR Shareholding
21st Sep 20102:38 pmRNSDirector/PDMR Shareholding
13th Sep 20104:41 pmRNSDirector/PDMR Shareholding
1st Sep 20102:59 pmRNSDirector/PDMR Shareholding
1st Sep 20102:55 pmRNSExercise of Options
11th Aug 20102:27 pmRNSDirector/PDMR Shareholding
9th Aug 20109:51 amRNSHalf Yearly Report
15th Jun 201010:24 amRNSDirector/PDMR Shareholding
8th Jun 201010:20 amRNSDirector/PDMR Shareholding
26th Apr 20109:46 amRNSDirector/PDMR Shareholding
13th Apr 201010:10 amRNSDirector/PDMR Shareholding
31st Mar 20109:10 amRNSFinal Results
26th Nov 20092:41 pmRNSDirector/PDMR Shareholding
24th Nov 20099:12 amRNSDirector/PDMR Shareholding
12th Nov 20099:19 amRNSDirector/PDMR Shareholding
30th Sep 20097:00 amRNSTotal Voting Rights
11th Sep 20097:51 amRNSDirector/PDMR Shareholding - Replacement
10th Sep 20098:48 amRNSDirector/PDMR Shareholding
4th Sep 200912:21 pmRNSIssue of Equity
16th Jul 20099:17 amRNSHalf Yearly Report
25th Mar 200911:06 amRNSDirector/PDMR Shareholding
24th Mar 20099:58 amRNSPreliminary Results
3rd Nov 20083:11 pmRNSDirector/PDMR Shareholding
30th Sep 20082:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.